The combination of cisplatin and topotecan as a second-line treatment for patients with advanced/recurrent uterine cervix cancer

We retrospectively reviewed outcomes of treatments with cisplatin and topotecan in patients with previously-treated uterine cervix cancer. We analyzed the medical records of patients with advanced (stage IVB) or recurrent or persistent squamous or non-squamous cell carcinoma of the cervix, who were...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Ji Young, Song, Ik-Chan, Ko, Young Bok, Lee, Hyo Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902288/
https://www.ncbi.nlm.nih.gov/pubmed/29620661
http://dx.doi.org/10.1097/MD.0000000000010340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902288/
https://www.ncbi.nlm.nih.gov/pubmed/29620661
http://dx.doi.org/10.1097/MD.0000000000010340

Ejemplares similares